People · Operator
Named in public records as an officer, director or promoter · active 2017–2017 · Other Health Care
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Apervita, Inc. | — | Other Health Care | Series B | $68.0M | $499.7M | 2017 |
David Shreiner at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside David Shreiner on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Michael Liang | 1 | 9 |
| Adam Koopersmith | 1 | 7 |
| James Bradley | 1 | 6 |
| Paul Magelli | 1 | 4 |
| Kevin Hutchinson | 1 | 4 |
| Mark Achler | 1 | 4 |
| Sarah London | 1 | 3 |
| Kevin Weinstein | 1 | 3 |
| Aaron Symanski | 1 | 2 |
| Aaron J Symanski | 1 | 1 |
| Brad Ryan | 1 | 1 |
| David Tuttle | 1 | 1 |
| Paul J Magelli | 1 | 1 |
| Geoff J Phillips | 1 | 1 |
| Mark J Achler | 1 | 1 |
| Kenneth Jakobsen | 1 | 1 |
| Blackford Middleton | 1 | 1 |
| Michael Oltman | 1 | 1 |
| William McNally | 1 | 1 |
| Noah Lewis | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.